Home Top Movers Companies Concepts

Market

Top Movers
Companies
Concepts

SEC Filings

AI Filing Analysis
Financial Reports
Current Reports
IPO Filings

Ownership

Institutional Holdings
Insider Trading

About

Data updates every 5 min
SEC EDGAR Source

© 2025–2026 StockGist|Information only, not investment advice

SCHEDULE 13G/A - Jasper Therapeutics, Inc. | StockGist | StockGist

Companies
JSPR
SCHEDULE 13G/A

Home Top Movers Companies Concepts

Home Filings JSPRSCHEDULE 13G/A

SCHEDULE 13G/A

Beneficial Ownership

Amendment

Jasper Therapeutics, Inc.

Filed Feb 11, 2025

Accepted Feb 10, 2025, 7:00 PM ET

CIK 0001788028

View on SEC.gov Company Profile

Beneficial Ownership Report

Passive Investment

Shares Owned

15,001,353

Reporting Person

Jasper Therapeutics, Inc.

Person Type

PN

CUSIP: 471871202

Amendment History

11 filings

SCHEDULE 13G
Original
Feb 11, 20260000895421-26-000039
SCHEDULE 13G/A
Amendment 1
Viewing
Feb 11, 20250001213900-25-012186
SCHEDULE 13G/A
Amendment 2
Viewing
Feb 11, 20250001213900-25-012186
SCHEDULE 13G/A
Amendment 3
Jul 17, 20250002052113-25-003206
SCHEDULE 13G/A
Amendment 4
Jul 17, 20250002052113-25-003206
SCHEDULE 13G/A
Amendment 5
Nov 7, 20250000895421-25-000572
SCHEDULE 13G/A
Amendment 6
Nov 7, 20250000895421-25-000572
SCHEDULE 13G/A
Amendment 7
Nov 12, 20250000919574-25-006584
SCHEDULE 13G/A
Amendment 8
Nov 12, 20250000919574-25-006584
SCHEDULE 13G/A
Amendment 9
Nov 14, 20250001765710-25-000005
SCHEDULE 13G/A
Amendment 10
Latest
Nov 14, 20250001765710-25-000005

Key Facts

Shares Owned

15,001,353

Recent Filings

Jasper Therapeutics, Inc.5 days ago

Jasper Therapeutics, Inc.5 days ago

Jasper Therapeutics, Inc.1 months ago

Jasper Therapeutics, Inc.1 months ago

Jasper Therapeutics, Inc.1 months ago

Data Sources

Original SEC Filing SEC EDGAR Company Page

Market

Top Movers
Companies
Concepts

SEC Filings

AI Filing Analysis
Financial Reports
Current Reports
IPO Filings

Ownership

Institutional Holdings
Insider Trading

About

Data updates every 5 min
SEC EDGAR Source

© 2025–2026 StockGist|Information only, not investment advice